Antidepressant medicine use in Australia has shown a forecasted increase from 138.1 units in 2024 to 151.4 units in 2028, measured in Defined Daily Dosage per thousand persons per day. An upward trend is seen year-on-year, with a compounded annual growth rate (CAGR) of approximately 2.3% from 2024 to 2028. This consistent increase suggests growing prevalence or diagnosis of depressive disorders, better accessibility to medications, or an evolving medical protocol favoring long-term use.
Future trends to watch for include the impact of mental health awareness campaigns, potential new entries of generic antidepressants, and evolving healthcare policies impacting prescription practices. These factors will be crucial in shaping the trajectory of antidepressant usage in Australia.
